Which biotech milestones deserve attention, and what uncertainty could each one change?
A catalyst matters when it is tied to a clear clinical, regulatory or commercial question. Record whether the date is scheduled, estimated or already completed, identify the primary source, and define the decision uncertainty the event could resolve. This avoids treating rumor, company guidance and regulator-confirmed milestones as equivalent evidence.
